Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MITF | O75030 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19558652 | 0.82 | MITF (0.33) | MITF | |
| SCHEMBL21704550 | 0.79 | TAS1R3 (0.33) | — | |
| SCHEMBL24132640 | 0.74 | PIK3CG (0.32) | — | |
| SCHEMBL22342802 | 0.74 | — | — | |
| SCHEMBL1755746 | 0.70 | MITF (0.32) | MITF | |
| SCHEMBL21720514 | 0.69 | STS (0.33) | — | |
| SCHEMBL418112 | 0.68 | MITF (0.33) | MITF | |
| SCHEMBL21718768 | 0.68 | HPGD (0.36) | — | |
| SCHEMBL21720373 | 0.68 | STS (0.32) | — | |
| SCHEMBL20121971 | 0.67 | MITF (0.32) | MITF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170174994-A1 | COMPOUND AND LIQUID CRYSTAL COMPOSITION EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174994-A1 | COMPOUND AND LIQUID CRYSTAL COMPOSITION EMPLOYING THE SAME | ZYX, ZRANB2, CXXC4 | MITF 2445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.